Key result
A review summarizing the pharmacodynamics, pharmacokinetics, and mechanisms of interaction between calcium antagonists and digoxin to help clinicians evaluate potential interactions.
This review summarizes the pharmacodynamics, pharmacokinetics, and mechanisms of interaction between calcium antagonists and digoxin to help clinicians evaluate potential drug interactions.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to calcium antagonist-digoxin interactions; leaves open the need for outcome trials to guide monitoring.
Therapeutic uses of calcium antagonists have expanded to include not only ischemic heart disease but arrhythmias, systemic hypertension, congestive heart failure, and various pulmonary and gastrointestinal diseases. Many patients receiving a calcium antagonist concomitantly receive digoxin. Although the potential interaction between these agents has frequently been investigated, literature reports are confusing and inconsistent. We summarized the pharmacodynamics, pharmacokinetics, and mechanisms of interaction to help clinicians evaluate the potential calcium antagonist-digoxin interaction.
No takes yet. Share an insight, caveat, or question.
Vito et al. (1986) conducted a review in Patients receiving calcium antagonists and digoxin concomitantly. Calcium antagonists and digoxin interaction was evaluated. A review summarizing the pharmacodynamics, pharmacokinetics, and mechanisms of interaction between calcium antagonists and digoxin to help clinicians evaluate potential interactions.
Synapse has enriched 10 related papers. Consider them for comparative context: